Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 34921238

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Nat Med
Publication date
2022 Feb
First author
Fowler NH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Fowler NH
      type
      Author
    2. name
      Dickinson M
      type
      Author
    3. name
      Dreyling M
      type
      Author
    4. name
      Martinez-Lopez J
      type
      Author
    5. name
      Kolstad A
      type
      Author
    6. name
      Butler J
      type
      Author
    7. name
      Ghosh M
      type
      Author
    8. name
      Popplewell L
      type
      Author
    9. name
      Chavez JC
      type
      Author
    10. name
      Bachy E
      type
      Author
    11. name
      Kato K
      type
      Author
    12. name
      Harigae H
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Fowler NH
      type
      Author
    2. name
      Dickinson M
      type
      Author
    3. name
      Dreyling M
      type
      Author
    4. name
      Martinez-Lopez J
      type
      Author
    5. name
      Kolstad A
      type
      Author
    6. name
      Butler J
      type
      Author
    7. name
      Ghosh M
      type
      Author
    8. name
      Popplewell L
      type
      Author
    9. name
      Chavez JC
      type
      Author
    10. name
      Bachy E
      type
      Author
    11. name
      Kato K
      type
      Author
    12. name
      Harigae H
      type
      Author
    bibliography ids
    1. nci-bib-0c35970f03783092bd01bca7
    book metadata
    content sha256
    a918ee6f2317f4a78754d6cde3775691a59332a9c2ab81d81ee274467f3bb1ef
    document type
    citation
    dois
    1. 10.1038/s41591-021-01622-0
    electronic publication date
    display
    2021 Dec 17
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34921238
    immutable id
    pubmed:34921238@a918ee6f2317f4a78754d6cde3775691a59332a9c2ab81d81ee274467f3bb1ef
    journal
    abbreviation
    Nat Med
    issn electronic
    1546-170X
    issn print
    1078-8956
    issue
    2
    name
    Nature medicine
    nlm unique id
    9502015
    pages
    325-332
    volume
    28
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34921238
      provenance
      batch id
      3f4d1914d2afe41e9e70
      provider
      NCBI PubMed ESummary
      record sha256
      9aa5061ddb71c4590dfcfbe38f3ecaae559f19361c0976fa456ff7527dd05a9c
      response sha256
      0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
      retrieved at
      2026-09-09T23:48:06.522634+00:00
      publication date
      display
      2022 Feb
      precision
      month
      year
      2022
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34921238/
      title
      Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.

      Preserved source evidence · Independent clinical review pending · Not medical advice